These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27543589)

  • 1. Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study.
    Mor A; Petersen I; Sørensen HT; Thomsen RW
    BMJ Open; 2016 Aug; 6(8):e011523. PubMed ID: 27543589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study.
    Nørgaard M; Darvalics B; Thomsen RW
    BMJ Open; 2020 Dec; 10(12):e041875. PubMed ID: 33371039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of Community-based Antibiotic Prescriptions and Hospital-treated Infections in Individuals With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study, 2004-2012.
    Mor A; Berencsi K; Nielsen JS; Rungby J; Friborg S; Brandslund I; Christiansen JS; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
    Clin Infect Dis; 2016 Aug; 63(4):501-11. PubMed ID: 27353662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial.
    Tsilidis KK; Capothanassi D; Allen NE; Rizos EC; Lopez DS; van Veldhoven K; Sacerdote C; Ashby D; Vineis P; Tzoulaki I; Ioannidis JP
    Diabetes Care; 2014 Sep; 37(9):2522-32. PubMed ID: 24898303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study.
    Chang CH; Chang YC; Lin JW; Chen ST; Chuang LM; Lai MS
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1121-9. PubMed ID: 25555040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
    Horsdal HT; Mehnert F; Rungby J; Johnsen SP
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study.
    Jørgensen CH; Gislason GH; Andersson C; Ahlehoff O; Charlot M; Schramm TK; Vaag A; Abildstrøm SZ; Torp-Pedersen C; Hansen PR
    Cardiovasc Diabetol; 2010 Sep; 9():54. PubMed ID: 20843380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and determinants of new first-line antihyperglycaemic drug use in patients with type 2 diabetes mellitus.
    Geier AS; Wellmann I; Wellmann J; Kajüter H; Heidinger O; Hempel G; Hense HW
    Diabetes Res Clin Pract; 2014 Oct; 106(1):73-80. PubMed ID: 25139631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
    Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Nutter B; Jain A; Atreja A; Zimmerman RS
    Diabet Med; 2012 Aug; 29(8):1029-35. PubMed ID: 22248043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term metformin use and risk of pneumonia and related death in type 2 diabetes: a registry-based cohort study.
    Yang A; Shi M; Wu H; Lau ESH; Ma RCW; Kong APS; So WY; Luk AOY; Chan JCN; Chow E
    Diabetologia; 2021 Aug; 64(8):1760-1765. PubMed ID: 33844069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin use and risk of lactic acidosis in people with diabetes with and without renal impairment: a cohort study in Denmark and the UK.
    Li L; Jick S; Gopalakrishnan C; Heide-Jørgensen U; Nørrelund H; Sørensen HT; Christiansen CF; Ehrenstein V
    Diabet Med; 2017 Apr; 34(4):485-489. PubMed ID: 27504911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Glycemic Control and Magnitude of HbA
    Svensson E; Baggesen LM; Johnsen SP; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Thomsen RW
    Diabetes Care; 2017 Jun; 40(6):800-807. PubMed ID: 28404659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J; Mehta R; Donnelly R; Idris I
    Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle factors associated with type 2 diabetes and use of different glucose-lowering drugs: cross-sectional study.
    Ulrichsen SP; Mor A; Svensson E; Larsen FB; Thomsen RW
    PLoS One; 2014; 9(11):e111849. PubMed ID: 25369331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in selection and timing of first-line pharmacotherapy in older patients with type 2 diabetes diagnosed between 1994 and 2006.
    Foster PD; Mamdani MM; Juurlink DN; Shah BR; Paterson JM; Gomes T
    Diabet Med; 2013 Oct; 30(10):1209-13. PubMed ID: 23586333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin initiation and renal impairment: a cohort study in Denmark and the UK.
    Christiansen CF; Ehrenstein V; Heide-Jørgensen U; Skovbo S; Nørrelund H; Sørensen HT; Li L; Jick S
    BMJ Open; 2015 Sep; 5(9):e008531. PubMed ID: 26338686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and primary bone cancer risk in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Bone; 2021 Oct; 151():116037. PubMed ID: 34116220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.
    Grimes RT; Bennett K; Tilson L; Usher C; Smith SM; Henman MC
    Br J Clin Pharmacol; 2015 Jun; 79(6):1000-9. PubMed ID: 25521800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.